323 related articles for article (PubMed ID: 32718075)
1. PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging.
Katzenellenbogen JA
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32718075
[TBL] [Abstract][Full Text] [Related]
2. Optimization of the preparation of fluorine-18-labeled steroid receptor ligands 16alpha-[18F]fluoroestradiol (FES), [18F]fluoro furanyl norprogesterone (FFNP), and 16beta-[18F]fluoro-5alpha-dihydrotestosterone (FDHT) as radiopharmaceuticals.
Zhou D; Lin M; Yasui N; Al-Qahtani MH; Dence CS; Schwarz S; Katzenellenbogen JA
J Labelled Comp Radiopharm; 2014 May; 57(5):371-7. PubMed ID: 24861984
[TBL] [Abstract][Full Text] [Related]
3. Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies.
Venema CM; Mammatas LH; Schröder CP; van Kruchten M; Apollonio G; Glaudemans AWJM; Bongaerts AHH; Hoekstra OS; Verheul HMW; Boven E; van der Vegt B; de Vries EFJ; de Vries EGE; Boellaard R; Menke van der Houven van Oordt CW; Hospers GAP
J Nucl Med; 2017 Dec; 58(12):1906-1912. PubMed ID: 28912144
[TBL] [Abstract][Full Text] [Related]
4. Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.
Fowler AM; Chan SR; Sharp TL; Fettig NM; Zhou D; Dence CS; Carlson KE; Jeyakumar M; Katzenellenbogen JA; Schreiber RD; Welch MJ
J Nucl Med; 2012 Jul; 53(7):1119-26. PubMed ID: 22669982
[TBL] [Abstract][Full Text] [Related]
5. Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.
Talbot JN; Gligorov J; Nataf V; Montravers F; Huchet V; Michaud L; Ohnona J; Balogova S; Cussenot O; Daraï E; Lotz JP; Kerrou K
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):4-17. PubMed ID: 25693420
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal noninvasive imaging of progesterone receptor as a predictive biomarker of tumor responsiveness to estrogen deprivation therapy.
Chan SR; Fowler AM; Allen JA; Zhou D; Dence CS; Sharp TL; Fettig NM; Dehdashti F; Katzenellenbogen JA
Clin Cancer Res; 2015 Mar; 21(5):1063-70. PubMed ID: 25520392
[TBL] [Abstract][Full Text] [Related]
7. Androgen Receptor Imaging in the Management of Hormone-Dependent Cancers with Emphasis on Prostate Cancer.
Kairemo K; Hodolic M
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175938
[TBL] [Abstract][Full Text] [Related]
8. The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[
Katzenellenbogen JA
Nucl Med Biol; 2021 Jan; 92():24-37. PubMed ID: 32229068
[TBL] [Abstract][Full Text] [Related]
9. Serial [
Boers J; Venema CM; de Vries EFJ; Hospers GAP; Boersma HH; Rikhof B; Dorbritz C; Glaudemans AWJM; Schröder CP
Eur J Cancer; 2021 Feb; 144():151-161. PubMed ID: 33341447
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal Molecular Imaging of Progesterone Receptor Reveals Early Differential Response to Endocrine Therapy in Breast Cancer with an Activating
Kumar M; Salem K; Jeffery JJ; Yan Y; Mahajan AM; Fowler AM
J Nucl Med; 2021 Apr; 62(4):500-506. PubMed ID: 32859700
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Evaluation of
Antunes IF; Dost RJ; Hoving HD; van Waarde A; Dierckx RAJO; Samplonius DF; Helfrich W; Elsinga PH; de Vries EFJ; de Jong IJ
J Nucl Med; 2021 Aug; 62(8):1140-1145. PubMed ID: 33517325
[TBL] [Abstract][Full Text] [Related]
12. Determination of binding affinity of molecular imaging agents for steroid hormone receptors in breast cancer.
Salem K; Kumar M; Kloepping KC; Michel CJ; Yan Y; Fowler AM
Am J Nucl Med Mol Imaging; 2018; 8(2):119-126. PubMed ID: 29755845
[TBL] [Abstract][Full Text] [Related]
13. Clinical Potential of Estrogen and Progesterone Receptor Imaging.
Linden HM; Peterson LM; Fowler AM
PET Clin; 2018 Jul; 13(3):415-422. PubMed ID: 30100079
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancer.
Gemignani ML; Patil S; Seshan VE; Sampson M; Humm JL; Lewis JS; Brogi E; Larson SM; Morrow M; Pandit-Taskar N
J Nucl Med; 2013 Oct; 54(10):1697-702. PubMed ID: 23970364
[TBL] [Abstract][Full Text] [Related]
15. In vivo imaging of brain androgen receptors in rats: a [(18)F]FDHT PET study.
Khayum MA; Doorduin J; Antunes IF; Kwizera C; Zijlma R; den Boer JA; Dierckx RA; de Vries EF
Nucl Med Biol; 2015 Jun; 42(6):561-9. PubMed ID: 25735222
[TBL] [Abstract][Full Text] [Related]
16. Whole-Body Characterization of Estrogen Receptor Status in Metastatic Breast Cancer with 16α-18F-Fluoro-17β-Estradiol Positron Emission Tomography: Meta-Analysis and Recommendations for Integration into Clinical Applications.
Kurland BF; Wiggins JR; Coche A; Fontan C; Bouvet Y; Webner P; Divgi C; Linden HM
Oncologist; 2020 Oct; 25(10):835-844. PubMed ID: 32374053
[TBL] [Abstract][Full Text] [Related]
17. [
Filippi L; Urso L; Schillaci O; Evangelista L
Diagnostics (Basel); 2023 Aug; 13(15):. PubMed ID: 37568977
[TBL] [Abstract][Full Text] [Related]
18. Consecutive Prostate-Specific Membrane Antigen (PSMA) and Antigen Receptor (AR) PET Imaging Shows Positive Correlation with AR and PSMA Protein Expression in Primary Hormone-Naïve Prostate Cancer.
Al Jalali V; Wasinger G; Rasul S; Grubmüller B; Wulkersdorfer B; Balber T; Mitterhauser M; Simon J; Hacker M; Shariat S; Egger G; Zeitlinger M
J Nucl Med; 2023 Jun; 64(6):863-868. PubMed ID: 36657982
[TBL] [Abstract][Full Text] [Related]
19. Specific
Larimer BM; Dubois F; Bloch E; Nesti S; Placzek M; Zadra G; Hooker JM; Loda M; Mahmood U
J Nucl Med; 2018 Oct; 59(10):1538-1543. PubMed ID: 29853654
[TBL] [Abstract][Full Text] [Related]
20. Imaging Androgen Receptors in Breast Cancer with
Jacene H; Liu M; Cheng SC; Abbott A; Dubey S; McCall K; Young D; Johnston M; Van den Abbeele AD; Overmoyer B
J Nucl Med; 2022 Jan; 63(1):22-28. PubMed ID: 34049982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
